Chi-Chao Chen

1.6k citations
5 papers · 988 indexed · h-index 5
Topics
Protein Degradation and Inhibitors (2 papers)PI3K/AKT/mTOR signaling in cancer (1 paper)Sarcoma Diagnosis and Treatment (1 paper)

In The Last Decade

Chi-Chao Chen

5 papers receiving 979 citations

Peers

Chi-Chao Chen
Comparison fields: 5 of 78
  • Molecular Biology 689
  • Oncology 263
  • Cancer Research 230
  • Physiology 168
  • Pulmonary and Respiratory Medicine 153
Replace Rodrigo Leite de Oliveira with:
Rodrigo Leite de Oliveira Netherlands
Shohreh Varmeh United States
Cindy Hodakoski United States
Giovanni D’Ario Italy
Claudia Capparelli United States
Daniel Dauch Germany
Nicolás Herranz Spain
Nail Fatkhutdinov United States
Yingduan Cheng China
Hui-Kuan Lin United States
Chi-Chao Chen relative to Rodrigo Leite de Oliveira Netherlands Rodrigo Leite de Oliveira's profile →
Citations per field
00.5×4.3×
Rodrigo Leite de Oliveira · 1×
Citations per year

Countries citing papers authored by Chi-Chao Chen

Since Specialization
Citations

This map shows the geographic impact of Chi-Chao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Chao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Chao Chen more than expected).

Fields of papers citing papers by Chi-Chao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Chao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Chao Chen. The network helps show where Chi-Chao Chen may publish in the future.

Co-authorship network of co-authors of Chi-Chao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Chao Chen. A scholar is included among the top collaborators of Chi-Chao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Chao Chen. Chi-Chao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 201
2 101
3 114
4 278
5 294

About Chi-Chao Chen

Chi-Chao Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 5 papers that have together received 988 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Aging (28 citations), Cancer Research (230 citations) and Molecular Biology (689 citations). Chi-Chao Chen has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Scott W. Lowe, John P. Morris, Darjus F. Tschaharganeh, Chun‐Hao Huang, Nilgun Tasdemir, Timour Baslan, Christopher R. Vakoc, Ana Banito, Sha Tian and Jae‐Seok Roe. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026